Fifty young patients have now undergone scoliosis treatment with the ApiFix system.
Here are five things to know about ApiFix:
1. The system is approved in Europe and has the CE mark.
2. ApiFix is a non-fusion minimally invasive treatment for adolescent idiopathic scoliosis.
3. A clinical study shows there are many drawbacks to AIS surgery that don't exist with the ApiFix procedure, including high levels of blood loss, transfusions and neurologic deficit.
4. The company is currently raising funds to fast-forward sales and market efforts to launch the device.
5. ApiFix is currently a commercial-stage company.